No abstract available
Publication types
-
Clinical Trial, Phase I
-
Letter
MeSH terms
-
Antigens, CD20
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Humans
-
Killer Cells, Natural
-
Leukocytes, Mononuclear*
-
Lymphoma* / drug therapy
-
Rituximab